Acquired Temporal-Bone Cholesteatoma Imaging 

  • Author: Salomon Waizel-Haiat, MD; Chief Editor: Lawrence M Davis, MD   more...
 
Updated: May 25, 2011
 

Overview

A cholesteatoma, as shown in the images below, consists of an accumulation of desquamated keratin epithelium in the middle ear cleft or any other pneumatized portion of the temporal bone. The envelope of a cholesteatoma is termed a matrix, and desquamated keratin is shed continually by the matrix and forms the central mass of the cholesteatoma, similar to the layers of an onion. The term cholesteatoma is a misnomer, since the entity does not contain cholesterol.

Coronal high-resolution computed tomography scan sCoronal high-resolution computed tomography scan shows a cholesteatoma in the posterior epitympanum (blue arrow), erosion of the scutum (white arrow), and rectification of the cochlea (red arrow). Temporal bone, acquired cholesteatoma. Keratosis oTemporal bone, acquired cholesteatoma. Keratosis obturans. Coronal high-resolution CT scan shows destruction of the external auditory canal, lateral to the tympanic membrane (blue arrows), and accumulation of epithelium in the canal (red arrow). Temporal bone, acquired cholesteatoma. Coronal T1-Temporal bone, acquired cholesteatoma. Coronal T1-weighted MRI shows evident integrity of the dura without herniation of brain tissue. Gadolinium enhancement of the mastoid is seen; this corresponds with fibrosis seen at surgery. Temporal bone, acquired cholesteatoma. T1-weightedTemporal bone, acquired cholesteatoma. T1-weighted axial MRI shows a soft-tissue mass in the region of the right tegmen tympani.

Recent studies

Manolis et al described computed tomography (CT) scan findings in middle-ear cholesteatoma in 32 pediatric patients (age range, 3-14 y), 30 of whom presented with acquired cholesteatoma (AC) and 2 with congenital cholesteatoma. CT was performed using 1-mm or 2-mm axial and coronal sections of both temporal bones.

In 19 of the patients with AC (63.3%), CT showed a diffuse soft-tissue density isodense with muscle, and in 6 other patients, the mass mimicked inflammation. In the remaining 5 patients with AC, CT revealed a localized soft-tissue mass with partially lobulated contour. Ossicular erosion was detected in 23 AC patients (76.7%), abnormal pneumatization in 19 (63.3%), and erosion-blunting of spur and enlargement of middle ear or mastoid in 8 (26.7%). In the 2 patients with congenital cholesteatomas, CT revealed a soft-tissue mass with polypoid densities, and a semicircular canal fistula was detected in 1 case.[1]

Diffusion-weighted echo-planar imaging (DW-EPI) demonstrated a sensitivity of 83% and a specificity of 82% in the diagnosis of residual cholesteatoma, according to a study by Jindal et al. The report involved 50 patients who underwent DW-EPI before surgery. The modality confirmed cholesteatoma in all 15 patients who had a scan before first surgery, and it identified or excluded cholesteatoma correctly in 29 of 35 patients who underwent neuroimaging before second-look surgery.[2]

Preferred examination

Otoscopic examination is the most important diagnostic technique. In primary acquired cholesteatoma, a retraction pouch is seen in the attic and contains keratin debris. In secondary acquired cholesteatoma, a tympanic membrane perforation is seen in which the epithelium has migrated through the borders and already has reached the middle-ear space. In an infected cholesteatoma, moderate fetid secretions with osteitis and granulation tissue are seen; these can be in the form of inflammatory aural polyps.[3]

Conventional temporal-bone projections and special imaging procedures, such as high-resolution CT scanning and magnetic resonance imaging (MRI), are employed to complement physical examination and to determine the extent of the disease process, being utilized preoperatively to plan surgical treatment. CT scanning and MRI are useful when revision surgery is performed.

High-resolution CT scanning in the axial and coronal planes is the imaging procedure of choice in the diagnosis of temporal-bone cholesteatomas.

Limitations of techniques

Basically, conventional radiographic studies exhibit great limitations because of the complex anatomy of the temporal bone and the subtle changes induced by small cholesteatomas.

CT scans also have limitations. With CT, it is difficult to differentiate a cholesteatoma from granulation tissue, pus, and fluid, which are present in chronic otitis media without the presence of a cholesteatoma.

The principal limitation of MRI is the lack of bone conspicuity and detail due to the lack of mobile protons in dense cortical bone and signal void experienced when a radiofrequency pulse is applied. Because the major changes induced by a cholesteatoma in the temporal bone are produced within the bony framework, MRI has only a supportive role in the evaluation of subjacent extension of disease outside the confines of the temporal bone, intracranial extension, or rare vascular insult that may occur in large, chronic, or relapsing cases.

Next

Radiography

Conventional temporal-bone projections remain in use in many parts of the world where CT scanning and MRI are not available. Standard projections for the temporal bone include the Law, Schuller, Mayer, Owen, Chausse III, transorbital, Stenvers, submentovertical, and Towne views. Schuller, Stenvers, Towne, and submentovertical projections are the most useful in the diagnosis of acquired cholesteatoma of the temporal bone.

Schuller view

The Schuller view is a lateral view of the mastoid, obtained with the sagittal plane of the skull parallel to the film and with 30º-cephalocaudal angulation on the radiographic beam. This view shows the degree and extent of mastoid pneumatization, the status of the trabecular pattern, and the position of the lateral sinus.

Stenvers view

The Stenvers view is obtained with the patient facing the film and the head slightly flexed and rotated 45º toward the side opposite the examination. The radiographic beam is angulated 14º caudad. The long axis of the petrous pyramid is parallel to the plane of the film, and the entire pyramid, including its apex, is well visualized. This view shows the entire pyramid, arcuate eminence, internal auditory canal, porus acusticus, horizontal and vertical semicircular canals, vestibule, cochlea, mastoid antrum, and mastoid tip.

Submentovertical view

The submentovertical view (also termed axial or basal) is obtained from under the chin and has the advantage of showing both temporal bones on the same image. In this view, the external auditory canal, eustachian tube, middle ear (including the incus and the head of the malleus), mastoid air cells, styloid process, internal auditory canal, and petrous apex are visualized. This view also demonstrates the foramen ovale, foramen spinosum, and jugular foramen from the base of the skull.

Towne view

The Towne view is an anteroposterior projection with a 30º tilt. As in the submentovertical view, it allows comparison of both petrous pyramids and mastoids in the same image. The petrous apex, internal auditory canals, arcuate eminence, mastoid antrum, and mastoid process can be identified clearly.

High-technology imaging modalities have become the radiologic methods of choice in the study of acquired temporal-bone cholesteatoma.

Degree of confidence

Degree of confidence in radiography is low because of the complex anatomy of the temporal bone and the small radiologic changes induced by pathologic conditions. Interpretation of findings always depends on the experience of the physician.

False positives/negatives

The false-negative rate with plain radiographs is high.

Previous
Next

Computed Tomography

Direct thin-section CT scanning in axial and coronal planes is a must for optimal evaluation of temporal-bone anatomy and pathology. Axial images are obtained parallel to the infraorbitomeatal line to reduce the radiation dose to the lens of the eye.

Direct coronal images can be obtained in supine hanging-head position or prone with the neck extended. Axial images should include the top of the petrous apex to the inferior tip of the mastoid, and coronal images should be obtained from the anterior margin of the petrous apex to the posterior margin of the mastoid.

Contiguous 1- to 1.5-mm – thick sections should be obtained by using conventional sequential acquisition. A spiral technique may be used if a pitch of 1:1 also is used. A small (12-cm) field of view can be applied with scans for each ear, reconstructed separately by using a bone algorithm. Intravenous contrast enhancement is usually not required.

High-resolution CT scanning is ideal for the evaluation of middle-ear pathology. Contrast-enhanced CT scanning also is useful, if an intracranial complication is suspected and/or if a brain hernia (encephalocele) is present in the bed of the revision surgery. (See the image below.)

Advanced technology, such as multidetector-row scanning with submillimeter (0.5-mm) section thickness and high-speed rotation (0.5 second per rotation), has reinforced the benefits of CT scanning in assessing temporal-bone cholesteatomas.

Applications of CT scanning

CT scanning offers high-resolution images with a section thickness of approximately 1 mm, which allows for good visualization of the bony, ossicular, and inner-ear anatomies. On CT scans, good contrast is demonstrated for bone, soft tissue, and air.

CT scanning is the preferred method for evaluating chronic middle-ear disease, including acquired cholesteatoma, because of its ability to demonstrate bony destruction.

CT scanning is used to establish the surgical procedure needed in each patient. CT scanning helps to determine the extent of the cholesteatoma; the location and size of the sac; the status of the ossicular chain; the integrity of the facial canal, tegmen, and sinus plate; and the position of the dura, sigmoid sinus, and jugular bulb. (See the images below.)

Temporal bone, acquired cholesteatoma. Coronal higTemporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows an epitympanic cholesteatoma with erosion of the tegmen tympani and probable herniation of brain tissue into the middle ear. Temporal bone, acquired cholesteatoma. This image Temporal bone, acquired cholesteatoma. This image shows the integrity of the mastoid tegmen. Temporal bone, acquired cholesteatoma. Contrast-enTemporal bone, acquired cholesteatoma. Contrast-enhanced coronal CT scan shows destruction of right tegmen tympani and dural enhancement.

CT-scan findings

CT-scan findings in acquired temporal-bone cholesteatoma are characterized by a soft-tissue homogeneous mass with focal bone destruction. Cholesteatoma almost always presents as a complication of chronic otitis media; therefore, the middle-ear space appears cloudy as a result of granulation tissue, pus, and fluid.

Liu and Bergeron have proposed the following CT-scan findings in cholesteatoma[4] :

  • Erosion and destruction of the lateral wall of the attic (scutum) (shown in the images below)Coronal high-resolution computed tomography scan sCoronal high-resolution computed tomography scan shows a cholesteatoma in the posterior epitympanum (blue arrow), erosion of the scutum (white arrow), and rectification of the cochlea (red arrow). Temporal bone, acquired cholesteatoma. EpitympanicTemporal bone, acquired cholesteatoma. Epitympanic cholesteatoma. Coronal high-resolution CT scan of the right ear shows an eroded scutum and a soft-tissue mass between the ossicular chains. Temporal bone, acquired cholesteatoma. Coronal higTemporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows a soft-tissue mass in the epitympanum and over the oval window, an eroded scutum (red arrow), and an atelectatic tympanic membrane.
  • Widening of the aditus ad antrum
  • Displacement of the ossicular chain
  • Destruction of the ossicles (shown in the image below)Temporal bone, acquired cholesteatoma. Axial CT scTemporal bone, acquired cholesteatoma. Axial CT scan of left cholesteatoma. A soft-tissue mass in the middle ear with destruction of ossicles and erosion of the walls of middle ear cavity.
  • Labyrinthine fistula
  • Erosion of the facial canal
  • Dehiscence of the tympanic roof (tegmen tympani) (shown in the image below)Temporal bone, acquired cholesteatoma. Coronal higTemporal bone, acquired cholesteatoma. Coronal high-resolution CT scan in a patient who underwent 3 previous otologic surgeries in the right ear. Image shows tegmen dehiscence and a mastoid cavity filled with soft-tissue attenuation of uncertain origin, which is probably brain-tissue herniation, residual cholesteatoma, or fibrosis.
  • Destruction of the mastoid (automastoidectomy cavity) (see the image below)Temporal bone, acquired cholesteatoma. Axial CT scTemporal bone, acquired cholesteatoma. Axial CT scan of right cholesteatoma shows a large cavity in the right mastoid air cells; this is consistent with an automastoidectomy.
  • Dehiscence of the sigmoid plate
  • Erosion of the roof of the external auditory canal (posterosuperior wall)

Degree of confidence

CT scanning is considerably more sensitive than conventional radiography for detecting cholesteatomas.

False positives/negatives

Granulation tissue and a chronically infected middle-ear mucosa are almost impossible to differentiate from a cholesteatoma.

Previous
Next

Magnetic Resonance Imaging

Optimal MRI technique depends on the clinical situation and age of the patient. High–field-strength, contrast-enhanced imaging in the axial and coronal plane has been considered the criterion standard for evaluation of the internal auditory canal (IAC) and inner-ear structures.

Nonenhanced and gadolinium-contrast–enhanced T1-weighted images are compared in order to differentiate bright lesions (fat and blood products) from enhancing lesions visualized after contrast infusion. Three-dimensional (3D) fast spin-echo T2-weighted images allow high-resolution imaging of the IAC and labyrinth. A variety of 3D gradient-echo techniques with thin sections also are available.

The MRI characteristics of acquired temporal-bone cholesteatoma are demonstrated in the images below.

Temporal bone, acquired cholesteatoma. T1-weightedTemporal bone, acquired cholesteatoma. T1-weighted axial MRI shows a soft-tissue mass in the region of the right tegmen tympani. Temporal bone, acquired cholesteatoma. T1-weightedTemporal bone, acquired cholesteatoma. T1-weighted axial MRI. Hypointense soft-tissue mass in the region of right tegmen tympani extends intracranially. Temporal bone, acquired cholesteatoma. T2-weightedTemporal bone, acquired cholesteatoma. T2-weighted axial MRI. MRI shows a hyperintense mass in the region of right tegmen tympani with intracranial extension.

Gadolinium-based contrast agents have been linked to the development of nephrogenic systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD). The disease has occurred in patients with moderate to end-stage renal disease after they were given a gadolinium-based contrast agent to enhance MRI or magnetic resonance angiography scans. NSF/NFD is a debilitating and sometimes fatal disease.

Characteristics of NSF/NFD include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness.

Applications of MRI

The role of MRI in the evaluation of middle-ear pathology is limited. The most important contributions of MRI to the study of acquired temporal-bone cholesteatoma are the following:

  • Precise definition of the borders of large lesions
  • Depiction of the relationship of the lesion to intracranial structures
  • Help in evaluating intratemporal and extratemporal complications
  • Follow-up in patients who have undergone middle-ear surgery for a cholesteatoma

MRI defines the integrity of the dura, which is best appreciated with T2-weighted sequences, without the need for contrast material. However, in cases of dural infection, subtle contrast enhancement may be the only clue that dural involvement is present.

MRI delineates intracranial extension of the cholesteatoma or protrusion of the intracranial contents into the middle ear, when defects of the tegmen tympani or sinus plate are visualized on the CT scan. MRI is also indicated when the facial nerve is involved.

MRI findings

Acquired cholesteatomas generally produce low signal intensity on T1-weighted images, with no change after contrast administration, and high signal intensity on T2-weighted images.[5, 6]

MRI is also used to differentiate cholesteatomas from other temporal-bone lesions, such as cholesterol granulomas, granulation tissue, inflammatory mucosa, and scar tissue.

Cholesterol granulomas produce high signal intensity on both sequences, with no contrast enhancement. Granulation tissue and inflammatory mucosa generally produce a hypointense or intermediate signal on T1-weighted images and a hyperintense signal on T2-weighted images with contrast enhancement. Because of its fibrous nature and, possibly, the microvascular thrombosis phenomenon, it is necessary to obtain delayed contrast-enhanced images with a delay of 30–45 minutes after contrast-material administration.[7]

Organized scar tissue produces a hypointense intermediate signal on T1- and T2-weighted images with no contrast enhancement.

A study by Dubrulle et al showed the reliability of diffusion-weighted, fast spin-echo MRI in the detection of recurrent cholesteatoma in patients who have undergone middle-ear surgery.[8] Recurrent cholesteatoma was diagnosed if the lesion had low signal intensity on unenhanced T1-weighted images, showed no change in signal intensity on delayed contrast-enhanced T1-weighted images, and had high signal intensity on diffusion-weighted images obtained with a b factor of 800 sec/mm2.

The negative predictive value was 100%, which means that patients who show no signs of recurrent cholesteatoma on diffusion-weighted fast spin-echo images may not need second-look surgery.

Degree of confidence

MRI is considerably more sensitive than conventional radiography, but it is less sensitive than high-resolution CT scanning, because of the lack of bone delineation on MRI.

Previous
 
Contributor Information and Disclosures
Author

Salomon Waizel-Haiat, MD  Associate Professor of Otolaryngology, Anahuac University; Consulting Surgeon, Department of Otolaryngology, Hospital De Especialidades, National Medical Center SXXI, IMSS

Disclosure: Nothing to disclose.

Coauthor(s)

Jose German Grandvallet, MD  Consulting Surgeon, Department of Otolaryngology, Medica Sur Medical Center, Mexico

Disclosure: Nothing to disclose.

Anil Khosla, MBBS, MD  Assistant Professor, Department of Radiology, Saint Louis University School of Medicine, Veterans Affairs Medical Center of St Louis

Anil Khosla, MBBS, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, North American Spine Society, and Radiological Society of North America

Disclosure: Nothing to disclose.

Specialty Editor Board

David S Levey, MD, PhD  Orthopedic/Neurospinal MRI TeleRadiologist, Poolside MRI, San Antonio, TX

David S Levey, MD, PhD is a member of the following medical societies: American Roentgen Ray Society, Radiological Society of North America, and Texas Medical Association

Disclosure: Nothing to disclose.

Bernard D Coombs, MB, ChB, PhD  Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

C Douglas Phillips, MD  Director of Head and Neck Imaging, Division of Neuroradiology, New York Presbyterian Hospital, Weill Cornell Medical College

C Douglas Phillips, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Society of Head and Neck Radiology, American Society of Neuroradiology, Association of University Radiologists, and Radiological Society of North America

Disclosure: Nothing to disclose.

Robert M Krasny, MD  Resolution Imaging Medical Corporation

Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America

Disclosure: Nothing to disclose.

Chief Editor

Lawrence M Davis, MD  Assistant Professor of Diagnostic Imaging (Clinical), Department of Diagnostic Imaging, Warren Alpert Medical School at Brown University

Lawrence M Davis, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, Radiological Society of North America, and Rhode Island Medical Society

Disclosure: Nothing to disclose.

References
  1. Manolis EN, Filippou DK, Tsoumakas C, Diomidous M, Cunningham MJ, Katostaras T, et al. Radiologic evaluation of the ear anatomy in pediatric cholesteatoma. J Craniofac Surg. May 2009;20(3):807-10. [Medline].

  2. Jindal M, Doshi J, Srivastav M, Wilcock D, Irving R, De R. Diffusion-weighted magnetic resonance imaging in the management of cholesteatoma. Eur Arch Otorhinolaryngol. Feb 2010;267(2):181-5. [Medline].

  3. Manolis EN, Filippou DK, Tsoumakas C, Diomidous M, Cunningham MJ, Katostaras T, et al. Radiologic Evaluation of the Ear Anatomy in Pediatric Cholesteatoma. J Craniofac Surg. Apr 22 2009;[Medline].

  4. Liu DP, Bergeron RT. Contemporary radiologic imaging in the evaluation of middle ear-attic-antral complex cholesteatomas. Otolaryngol Clin North Am. Oct 1989;22(5):897-909. [Medline].

  5. De Foer B, Vercruysse JP, Pilet B, et al. Single-shot, turbo spin-echo, diffusion-weighted imaging versus spin-echo-planar, diffusion-weighted imaging in the detection of acquired middle ear cholesteatoma. AJNR Am J Neuroradiol. Aug 2006;27(7):1480-2. [Medline].

  6. Cimsit NC, Cimsit C, Baysal B, Ruhi IC, Ozbilgen S, Aksoy EA. Diffusion-weighted MR imaging in postoperative follow-up: Reliability for detection of recurrent cholesteatoma. Eur J Radiol. Feb 19 2009;[Medline].

  7. Williams MT, Ayache D, Alberti C, et al. Detection of postoperative residual cholesteatoma with delayed contrast-enhanced MR imaging: initial findings. Eur Radiol. Jan 2003;13(1):169-74. [Medline].

  8. Dubrulle F, Souillard R, Chechin D, et al. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology. Feb 2006;238(2):604-10. [Medline]. [Full Text].

Previous
Next
 
Coronal high-resolution computed tomography scan shows a cholesteatoma in the posterior epitympanum (blue arrow), erosion of the scutum (white arrow), and rectification of the cochlea (red arrow).
Temporal bone, acquired cholesteatoma. Epitympanic cholesteatoma. Coronal high-resolution CT scan of the right ear shows an eroded scutum and a soft-tissue mass between the ossicular chains.
Temporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows a right epitympanic cholesteatoma, with erosion of the tegmen, ossicular chain (1), and facial nerve (2).
Temporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows a soft-tissue mass in the epitympanum and over the oval window, an eroded scutum (red arrow), and an atelectatic tympanic membrane.
Temporal bone, acquired cholesteatoma. Multiple coronal CT scans show a soft-tissue mass (cholesteatoma) extending into the mastoid pneumatic system. The mastoid portion of the facial nerve (blue arrow) is seen.
Temporal bone, acquired cholesteatoma. Keratosis obturans. Coronal high-resolution CT scan shows destruction of the external auditory canal, lateral to the tympanic membrane (blue arrows), and accumulation of epithelium in the canal (red arrow).
Temporal bone, acquired cholesteatoma. Keratosis obturans. Coronal CT scan shows a soft-tissue mass (epithelium) obstructing the external auditory canal (blue arrow).
Temporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows a mastoid cavity (canal-wall-down mastoidectomy) in the left ear.
Temporal bone, acquired cholesteatoma. Coronal CT of right cholesteatoma. A large soft-tissue mass in the right middle ear extending medial to the ossicles. The scutum is eroded and tympanic membrane is retracted. Note associated erosion of tegmen tympani. The normal left ear is shown for comparison.
Temporal bone, acquired cholesteatoma. Axial CT scan of left cholesteatoma. A soft-tissue mass in the middle ear with destruction of ossicles and erosion of the walls of middle ear cavity.
Temporal bone, acquired cholesteatoma. Axial CT scan of right cholesteatoma shows a large cavity in the right mastoid air cells; this is consistent with an automastoidectomy.
Temporal bone, acquired cholesteatoma. Coronal high-resolution CT scan shows an epitympanic cholesteatoma with erosion of the tegmen tympani and probable herniation of brain tissue into the middle ear.
Temporal bone, acquired cholesteatoma. This image shows the integrity of the mastoid tegmen.
Temporal bone, acquired cholesteatoma. Axial MRI was used to identify the integrity of the brain tissue and a small right temporal-bone cholesteatoma. This produces a low signal intensity on T1-weighted images and high signal intensity on T2-weighted images and, sometimes, peripheral contrast enhancement.
Temporal bone, acquired cholesteatoma. Coronal MRI.
Temporal bone, acquired cholesteatoma. Coronal high-resolution CT scan in a patient who underwent 3 previous otologic surgeries in the right ear. Image shows tegmen dehiscence and a mastoid cavity filled with soft-tissue attenuation of uncertain origin, which is probably brain-tissue herniation, residual cholesteatoma, or fibrosis.
Temporal bone, acquired cholesteatoma. Coronal T1-weighted MRI shows evident integrity of the dura without herniation of brain tissue. Gadolinium enhancement of the mastoid is seen; this corresponds with fibrosis seen at surgery.
Temporal bone, acquired cholesteatoma. Coronal CT scan in a 70-year-old patient with right-sided, long-standing, temporal-bone cholesteatoma. Image shows extensive erosion.
Temporal bone, acquired cholesteatoma. Contrast-enhanced coronal CT scan was obtained to rule out intracranial complications.
Temporal bone, acquired cholesteatoma. Contrast-enhanced coronal CT scan shows destruction of right tegmen tympani and dural enhancement.
Temporal bone, acquired cholesteatoma. T1-weighted axial MRI shows a soft-tissue mass in the region of the right tegmen tympani.
Temporal bone, acquired cholesteatoma. T1-weighted axial MRI. Hypointense soft-tissue mass in the region of right tegmen tympani extends intracranially.
Temporal bone, acquired cholesteatoma. T2-weighted axial MRI. MRI shows a hyperintense mass in the region of right tegmen tympani with intracranial extension.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.